Polyrizon Ltd. (NASDAQ:PLRZ) Short Interest Up 48.8% in August

Polyrizon Ltd. (NASDAQ:PLRZ) was the recipient of a significant increase in short interest during the month of August. As of August 14th, there was short interest totaling 94,216 shares, an increase of 48.8% from the July 30th total of 63,322 shares. Currently, 4.5% of the company’s shares are short sold. Based on an average daily volume of 59,143 shares, the short-interest ratio is currently 1.6 days.

Analysts Set New Price Targets

A number of equities analysts have commented on the stock. Wall Street Zen upgraded shares of Polyrizon from a “sell” rating to a “hold” rating in a research note on Sunday, June 7th. Weiss Ratings raised shares of Polyrizon from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, August 14th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the company presently has a consensus rating of “Sell”.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Polyrizon stock. Jane Street Group LLC purchased a new stake in Polyrizon Ltd. (NASDAQ:PLRZ) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 14,032 shares of the company’s stock, valued at approximately $119,000. Jane Street Group LLC owned approximately 1.35% of Polyrizon as of its most recent filing with the SEC.

Polyrizon Price Performance

Shares of PLRZ traded down $0.53 during midday trading on Wednesday, reaching $13.83. 33,906 shares of the stock were exchanged, compared to its average volume of 64,408. Polyrizon has a 52 week low of $2.88 and a 52 week high of $18.20. The company’s 50 day moving average is $12.43 and its two-hundred day moving average is $13.12.

About Polyrizon

Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.